Redhill Biopharma Stock (NASDAQ: RDHL) stock price, news, charts, stock research, profile.
Open | $0.36 |
Close | $0.35 |
Volume / Avg. | 212.64K / 268.82K |
Day Range | 0.35 - 0.36 |
52 Wk Range | 0.26 - 3.28 |
Market Cap | $11.45M |
P/E Ratio | 0.09 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 40 |
Short Interest | 1.73% |
Days to Cover | 1.4 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Redhill Biopharma (NASDAQ:RDHL) through any online brokerage.
Other companies in Redhill Biopharma’s space includes: Cumberland (NASDAQ:CPIX), Iterum Therapeutics (NASDAQ:ITRM), Cocrystal Pharma (NASDAQ:COCP), Kiora Pharmaceuticals (NASDAQ:KPRX) and Jaguar Health (NASDAQ:JAGX).
There is no analysis for Redhill Biopharma.
Redhill Biopharma has a consensus price target of $21.50.
The stock price for Redhill Biopharma (NASDAQ: RDHL) is $0.3592 last updated July 24, 2024 at 7:45 PM EDT.
There are no upcoming dividends for Redhill Biopharma.
Redhill Biopharma’s Q2 earnings are confirmed for Thursday, August 15, 2024.
There is no upcoming split for Redhill Biopharma.
Redhill Biopharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.